Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Questcor Pharmaceuticals Inc (QCOR)    
$37.61 0.75 (2.03%) as of 4:30 Mon 5/20


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 63,490,000 as of 6/30
Market Cap: 2.39(B)
Last Volume: 1,399,565 Avg Vol: 2,078,893
52 Week Range: $17.83 - $57.64
Level I Sector: Industrials
Level II Sector:   Diversified Services
Level III Sector:      Rental & Leasing Services

Member Indexes:
    AMEX COMPOSITE  

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Questcor Pharmaceuticals is a pharmaceutical company. Co.'s primary product is H.P. Acthar® Gel (repository corticotropin injection), an injectable drug used for the treatment of exacerbations of multiple sclerosis in adults, proteinuria in the nephrotic syndrome of the idiopathic type, and infantile spasms in infants and children. Co. also markets Doral® (quazepam), which is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. Co. has registered trademarks on H.P. Acthar® Gel and Doral®.
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 66,000 66,050
Total Buy Value $0 $0 $1,597,096 $1,598,596
Total People Bought 0 0 3 4
Total Buy Transactions 0 0 4 5
Total Shares Sold 274,687 374,687 609,417 2,145,423
Total Sell Value $10,394,341 $13,408,017 $25,120,589 $79,326,845
Total People Sold 2 2 3 8
Total Sell Transactions 8 11 18 44
End Date 2013-02-21 2012-11-20 2012-05-22 2011-05-23

   
Records found: 266
  Page 1 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Thompson Virgil D Director   –       •      –    2013-05-14 4 S $37.46 $187,300 D/D (5,000) 25,000 13%     
   Thompson Virgil D Director   –       •      –    2013-05-14 4 OE $4.75 $23,750 D/D 5,000 30,000     -
   Bailey Don M President and CEO   •       •      –    2013-05-14 4 S $40.40 $6,492,062 I/I (160,000) 99,000 13%     
   Bailey Don M President and CEO   •       •      –    2013-05-14 4 OE $5.09 $814,400 I/I 160,000 259,000     -
   Bailey Don M President and CEO   •       •      –    2013-05-13 4 OE $5.09 $101,800 I/I 20,000 119,000     -
   Bailey Don M President and CEO   •       •      –    2013-05-13 4 S $36.70 $734,000 I/I (20,000) 99,000 2%     
   Thompson Virgil D Director   –       •      –    2013-05-09 4 S $35.00 $76,545 D/D (2,187) 25,000 -6%     
   Thompson Virgil D Director   –       •      –    2013-05-09 4 OE $4.75 $10,388 D/D 2,187 27,187     -
   Bailey Don M President and CEO   •       •      –    2013-04-25 4 S $30.06 $301,572 I/I (10,031) 99,000 -26%     
   Bailey Don M President and CEO   •       •      –    2013-04-25 4 OE $5.09 $51,058 I/I 10,031 109,031     -
   Bailey Don M President and CEO   •       •      –    2013-04-24 4 OE $5.09 $50,742 I/I 9,969 108,969     -
   Bailey Don M President and CEO   •       •      –    2013-04-24 4 S $30.00 $299,102 I/I (9,969) 99,000 -24%     
   Thompson Virgil D Director   –       •      –    2013-03-21 4 S $35.00 $1,662,500 D/D (47,500) 25,000 -5%     
   Thompson Virgil D Director   –       •      –    2013-03-21 4 OE $1.47 $159,775 D/D 42,500 72,500     -
   Bailey Don M President and CEO   •       •      –    2013-03-13 4 S $32.06 $641,260 I/I (20,000) 99,000 -16%     
   Bailey Don M President and CEO   •       •      –    2013-03-13 4 OE $5.09 $101,800 I/I 20,000 119,000     -
   Young David Chief Scientific Officer   •       –      –    2013-03-07 4 GD $0.00 $0 D/D 10,625 75,666     -
   Young David Chief Scientific Officer   •       –      –    2013-03-07 4 GA $0.00 $0 I/I 10,625 10,625     -
   Young David Chief Scientific Officer   •       –      –    2013-02-24 4 A $0.00 $0 D/D 71,332 85,235     -
   Cartt Stephen Lahue Chief Operating Officer   •       –      –    2013-02-24 4 A $0.00 $0 D/D 86,887 175,085     -
   Mulroy Michael H. Sr VP, CFO & General Counsel   •       –      –    2013-02-24 4 A $0.00 $0 D/D 52,143 54,260     -
   Bailey Don M President and CEO   •       •      –    2013-02-24 4 A $0.00 $0 D/D 241,953 340,953     -
   Medeiros David Jeffrey EVP and CTO   •       –      –    2013-02-24 4 A $0.00 $0 D/D 54,099 117,127     -
   Young David Chief Scientific Officer   •       –      –    2013-02-24 4/A A $0.00 $0 D/D 71,325 85,821     -
   Cartt Stephen Lahue Chief Operating Officer   •       –      –    2013-02-24 4/A A $0.00 $0 D/D 86,879 175,077     -
  266 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2010 J3SG.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us